PPD targets NJ, PA
PPD’s acquisition of Merck’s vaccine testing laboratory will give it a geographic location from which it can compete for business with its “number one competitor”, which is well established in the north east of the US.
Archives for November 19, 2009
Further boost for Covance’s biomarker offering in RBM deal
Covance will outsource biomarker activities to US laboratory group Rules-Based Medicine (RBM) in an exclusive deal announced yesterday.
Reimportation is “legislative madness”
It is “legislative madness” to allow reimportation in the US, according to the chair of EAASM who spoke at AAPS about Europe’s “porous supply chain” and how it could affect the standard of medicines in the States.
UCB to cut 200 jobs in UK and Belgium
Belgian biotech UCB is to reduce workforce 2 per cent as part of R&D restructuring plan according to various reports.
Appointments at Xoma and Watson Pharmaceuticals, plus a new role for Fred Hasaan – People on the move
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Xoma and Watson Pharmaceuticals, plus a new role for Fred Hasaan.
Vaccine demand a friend to Pall in Q1; but sales still fall 5.4%
Continued high demand for vaccine manufacturing technologies saw life sciences emerge as one of the few positives for industrial processing specialist Pall in Q1.